These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 6770605)

  • 1. Inhibition of arachidonate metabolism by selected compounds in vitro with particular emphasis on the thromboxane A2 synthase pathway.
    Tobias LD; Hamilton JG
    Adv Prostaglandin Thromboxane Res; 1980; 6():453-6. PubMed ID: 6770605
    [No Abstract]   [Full Text] [Related]  

  • 2. [Suppression of platelet aggregation as a result of two-component inhibition of a polyenzyme system of thromboxane synthesis].
    Varfolomeev SD; Lakin KM; Mevkh AT; Novikova NV; Rukazenkov IuZ
    Dokl Akad Nauk SSSR; 1985; 282(1):194-6. PubMed ID: 3928305
    [No Abstract]   [Full Text] [Related]  

  • 3. Imidazo[1,5-a]pyridines: a new class of thromboxane A2 synthetase inhibitors.
    Ford NF; Browne LJ; Campbell T; Gemenden C; Goldstein R; Gude C; Wasley JW
    J Med Chem; 1985 Feb; 28(2):164-70. PubMed ID: 3918169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of thromboxane synthetase inhibitors on the action of bronchoactive agents and on arachidonate metabolism in the guinea pig tracheobronchopulmonary system].
    Kitamura S; Ishihara Y; Takaku F
    Nihon Kyobu Shikkan Gakkai Zasshi; 1984 Jan; 22(1):3-8. PubMed ID: 6539836
    [No Abstract]   [Full Text] [Related]  

  • 5. Biosynthesis of thromboxanes.
    Hammarström S; Diczfalusy U
    Adv Prostaglandin Thromboxane Res; 1980; 6():267-74. PubMed ID: 6770598
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversible inhibition of thromboxane A2 production by imidazole 2-hydroxybenzoate (ITF 182) in the arachidonic acid injected rat. A comparison with acetylsalicylic acid and indometacin.
    Pagella PG; Agozzino S; Bellavite O; Donà GC
    Arzneimittelforschung; 1984; 34(5):597-8. PubMed ID: 6432000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective blockade of thromboxane A2 synthesis during experimental E coli bacteremia in the goat. Effects on hemodynamics and lung water.
    Harlan J; Winn R; Weaver J; Hildebrandt J; Harker L
    Chest; 1983 May; 83(5 Suppl):75S-76S. PubMed ID: 6340988
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacology of thromboxane synthetase inhibitors.
    Aiken JW
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():253-8. PubMed ID: 6221532
    [No Abstract]   [Full Text] [Related]  

  • 9. Biology and biochemistry of thromboxane synthetase inhibitors.
    Gorman RR
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():235-40. PubMed ID: 6221529
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of thromboxane A2 biosynthesis in human platelets by burimamide.
    Allan G; Eakins KE; Kulkarni PS; Levi R
    Br J Pharmacol; 1980; 71(1):157-64. PubMed ID: 6781572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboxane a2: biosynthesis and effects on platelets.
    Granström E; Diczfalusy U; Hamberg M; Hansson G; Malmsten C; Samuelsson B
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():15-58. PubMed ID: 6216781
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of platelet aggregation by 1-alkylimidazole derivatives, thromboxane A synthetase inhibitors.
    Kayama N; Sakaguchi K; Kaneko S; Kubota T; Fukuzawa T; Kawamura S; Yoshimoto T; Yamamoto S
    Prostaglandins; 1981 Apr; 21(4):543-54. PubMed ID: 7196056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of the effects of inhibition of pulmonary thromboxane A2 synthase activity, in vivo and in vitro.
    McNamara DB; Kerstein MD; Harrington JK; Bellan JA; Graybar GB; Hyman AL; Kadowitz PJ
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():531-4. PubMed ID: 2526532
    [No Abstract]   [Full Text] [Related]  

  • 14. On the inhibitory potency of imidazole and its derivatives on thromboxane synthetase.
    Tai HH; Yuan B
    Biochem Biophys Res Commun; 1978 Jan; 80(1):236-42. PubMed ID: 623654
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of selective inhibition of thromboxane synthesis on renal function in humans.
    Zipser RD
    Am J Physiol; 1985 Jun; 248(6 Pt 2):F753-6. PubMed ID: 3839111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human platelet thromboxane synthetase by 11a-carbathromboxane A2 analogs.
    Gorman RR; Maxey KM; Bundy GL
    Biochem Biophys Res Commun; 1981 May; 100(1):184-90. PubMed ID: 7196228
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of thromboxane synthesis and platelet aggregation by pyridine and its derivatives.
    Tai HH; Lee N; Tai CL
    Adv Prostaglandin Thromboxane Res; 1980; 6():447-52. PubMed ID: 7189951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and pharmacological evaluation of thromboxane synthetase inhibitors.
    Gorman RR
    Adv Prostaglandin Thromboxane Res; 1980; 6():417-25. PubMed ID: 6247892
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin.
    Moncada S; Vane JR
    Pharmacol Rev; 1978 Sep; 30(3):293-331. PubMed ID: 116251
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of platelet thromboxane A2 synthase activity by sodium 5-(3'-pyridinylmethyl)benzofuran-2-carboxylate.
    Gorman RR; Johnson RA; Spilman CH; Aiken JW
    Prostaglandins; 1983 Aug; 26(2):325-42. PubMed ID: 6316421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.